We accelerate technology innovation in precision diagnostics to enable diseases to be detected, treated and cured earlier for better outcomes with lower costs.
Location: United States, Texas, Houston
Employees: 11-50
Total raised: $103M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | Sahsen Ven... | sahsen.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 03.06.2022 | - | $50M | - |
| 11.01.2021 | - | $42M | - |
| 24.04.2018 | Series A | $11M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 03.04.2024 | Bio-Rad launches first Ultrasensitive Multiplexed Digital PC... | Highly Sensitive and Multiplexed Assay for the Detection, Discrimination, and Quantification of Key ... | cambridgen... |
| 03.06.2022 | NuProbe Closes $50M Funding | NuProbe Global, a Houston, TX- and Shanghai, China-based genomics and molecular diagnostics company,... | finsmes.co... |
| 26.07.2021 | NuProbe Announces New Research and New Product on DNA Micros... | prnewswire... | |
| 26.07.2021 | NuProbe : Announces New Research and New Product on DNA Micr... | HOUSTON, July 26, 2021 /PRNewswire/ -- NuProbe Global, a genomics and molecular diagnostics company ... | marketscre... |
| 07.07.2021 | China Launches the World's Largest Real-World Study on Scree... | prnewswire... | |
| 22.02.2021 | NuProbe Launches Liquid Biopsy Pan-Cancer NGS Panel | prnewswire... | |
| 11.01.2021 | NuProbe Raises $42M in Funding | NuProbe, a Houston, USA, Shanghai, China and Suzhou, China-based genomics and molecular diagnostics ... | citybizlis... |
| 11.01.2021 | NuProbe Raises $42M in Funding | NuProbe, a Houston, USA, Shanghai, China and Suzhou, China-based genomics and molecular diagnostics ... | archive.ci... |
| 11.01.2021 | NuProbe Closes $42M Fundraising | prnewswire... | |
| 11.01.2021 | NuProbe Raises $42M in Funding | NuProbe, a Houston, USA, Shanghai, China and Suzhou, China-based genomics and molecular diagnostics ... | finsmes.co... |
Show more